<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is one of the leading <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Through genome wide association studies, several single nucleotide polymorphisms scattered in the genome emerged to be influential in the development of <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in some populations </plain></SENT>
<SENT sid="2" pm="."><plain>However, replicative studies failed to prove a particular SNP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> association in populations and ethnic groups </plain></SENT>
<SENT sid="3" pm="."><plain>Cyclooxygenase-2 (PTGS2) is a crucial enzyme involved in the metabolism of <z:chebi fb="11" ids="26333">prostaglandins</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this replicative study is to investigate the possible association between PTGS2 -765G&gt;C polymorphism and <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk in a subset of Iranian population </plain></SENT>
<SENT sid="5" pm="."><plain>A total of 110 patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and 120 controls were genotyped for PTGS2 -765G&gt;C polymorphism by using polymerase chain reaction-based restriction fragment length polymorphism </plain></SENT>
<SENT sid="6" pm="."><plain>There were no significant differences in the genotype and allele frequencies of PTGS2 -765G&gt;C between two groups except in irregular aspirin or <z:chebi fb="2" ids="35475">non-steroidal anti-inflammatory drugs</z:chebi> (<z:chebi fb="1" ids="35475">NSAID</z:chebi>) consumers </plain></SENT>
<SENT sid="7" pm="."><plain>Frequencies of genotypes and alleles were as follows: GG = 44.2, GC = 48.3, CC = 7.5%, in controls and GG = 34.55, GC = 60.9, CC = 4.55% in cases </plain></SENT>
<SENT sid="8" pm="."><plain>Regarding the allele frequency, the following values were found: G = 65, C = 35% in cases and 68.3, 31.7% in the controls, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>In irregular aspirin or <z:chebi fb="1" ids="35475">NSAID</z:chebi> consumers combined GC+CC genotype was found to be a risk genotype (OR = 1.933, 95% CI: 1.067-3.501, P = 0.036) </plain></SENT>
<SENT sid="10" pm="."><plain>Overall, no significant relation was found between this polymorphism and <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in Iranians </plain></SENT>
<SENT sid="11" pm="."><plain>However, in irregular aspirin or <z:chebi fb="1" ids="35475">NSAID</z:chebi> consumers the combined GC+CC genotype proved to be a risk genotype </plain></SENT>
</text></document>